Ruby John Anto
7PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 12, 2024
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated 'Orphan Drug', for the Treatment of Hepatocellular Carcinoma.Chenicheri Kizhakkeveettil Keerthana, Sreekumar U Aiswarya, Tennyson P Rayginia
|Jan 12, 2024
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma.Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Sadiq Chembothumparambil Shifana
|Jun 28, 2023
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future.Daniel L Pouliquen, Koraljka Gall Trošelj, Ruby John Anto
|May 19, 2023
A potent bioactive fraction against colon cancer from <i>Plectranthus vettiveroides</i>.Faisal M Athikkavil, Sreekumar U Aiswarya, Remya Johny
|Aug 10, 2022
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.Anwar Shabna, Jayesh Antony, Vinod Vijayakurup
Pageof 2
Frequent Collaborators
2 joint publications
Chenicheri Kizhakkeveettil Keerthana
1 joint publications
Faisal M Athikkavil
1 joint publications
Sreekumar U Aiswarya
1 joint publications
Remya Johny
1 joint publications
Meghna Sudhesh
1 joint publications
Amrutha A Nisthul
1 joint publications
Ravi S Lankalapalli
1 joint publications
Smitha V Bava
1 joint publications
Daniel L Pouliquen
1 joint publications
Koraljka Gall Trošelj
